Chemoinformaics analysis of ent-18-Acetoxy-8(14)-pimarene-15S,16-diol
| Molecular Weight | 364.526 | nRot | 4 |
| Heavy Atom Molecular Weight | 328.238 | nRig | 17 |
| Exact Molecular Weight | 364.261 | nRing | 3 |
| Solubility: LogS | -3.99 | nHRing | 0 |
| Solubility: LogP | 3.635 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 63.9525 |
| nHD | 2 | BPOL | 38.7195 |
| QED | 0.587 |
| Synth | 4.705 |
| Natural Product Likeliness | 3.284 |
| NR-PPAR-gamma | 0.038 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.857 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -4.722 |
| MDCK | 0.00002 |
| BBB | 0.714 |
| PPB | 0.883853 |
| VDSS | 0.916 |
| FU | 0.0771807 |
| CYP1A2-inh | 0.03 |
| CYP1A2-sub | 0.182 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.844 |
| CYP2c9-inh | 0.095 |
| CYP2c9-sub | 0.112 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.162 |
| CYP3a4-inh | 0.479 |
| CYP3a4-sub | 0.264 |
| CL | 3.605 |
| T12 | 0.21 |
| hERG | 0.004 |
| Ames | 0.023 |
| ROA | 0.044 |
| SkinSen | 0.029 |
| Carcinogencity | 0.073 |
| EI | 0.011 |
| Respiratory | 0.748 |
| NR-Aromatase | 0.713 |
| Antiviral | Yes |
| Prediction | 0.558541 |